ZYME FY 2018 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$53M+2.4% YoY

Gross Profit

-$4M-7.4% margin

Operating Income

-$33M-62.5% margin

Net Income

-$37M-68.9% margin

EPS (Diluted)

$-1.26

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$21M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$244M

Total Liabilities

$64M

Stockholders' Equity

-$145M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$52M	+2.4%
Gross Profit	-$4M	$11M	-136.8%
Operating Income	-$33M	-$9M	-268.2%
Net Income	-$37M	-$10M	-251.3%